News

Seelos Therapeutics Moves to OTC Market After Nasdaq Delisting

Seelos Therapeutics Moves to OTC Market After Nasdaq Delisting

Seelos Therapeutics Transitioning from Nasdaq to OTC Market

Seelos Therapeutics, Inc. (NASDAQ: SEEL) is a biopharmaceutical company focused on developing therapeutic solutions for central nervous system disorders and rare diseases. Recently, the company received an official notice from the Nasdaq Hearings Panel regarding the delisting of its common stock.

Reasons Behind the Delisting

This delisting decision is a direct consequence of Seelos' inability to meet Nasdaq’s minimum stockholder equity requirement. Despite being given an extension until a set date to rectify this compliance issue, Seelos fell short on this occasion.

Transition to OTCQB Market

As a result of the Nasdaq’s ruling, trading for Seelos will be suspended on Nasdaq starting from a specific date, after which the company plans to transition its trading to the OTCQB market. Although this move allows for continued trading, there remains uncertainty regarding the sustainability of the company’s stock in over-the-counter markets.

Recent Developments from Seelos

This notice comes shortly after Seelos Therapeutics entered into a material transfer agreement with the Department of Defense. This partnership aims to conduct a clinical trial using Seelos' innovative compound, referred to as SLS-002, which is designed to address the challenges associated with PTSD in military personnel and veterans.

Clinical Trial Goals

The research, set to be executed by the U.S. Army Medical Material Development Activity (USAMMDA), will focus on evaluating the effectiveness, safety, and tolerability of SLS-002. This clinical trial is crucial for understanding and improving treatment options available for those who suffer from PTSD, a condition common among military personnel.

Market Response and Pricing

In light of the recent developments, shares of SEEL witnessed a significant decrease, trading approximately 45.32% lower, with stock prices hovering around $1.34 per share. This downturn reflects investor sentiment regarding the future of Seelos in light of the impending transition to the OTC market.

Conclusion

The transition of Seelos Therapeutics from Nasdaq to the OTC market marks a challenging period for the company. However, their ongoing commitment to research and development in the area of PTSD treatments demonstrates their dedication to addressing serious health issues within the military community. Investors will be observing how this transition affects Seelos' capacity to advance its projects and contribute positively to the healthcare landscape.

Frequently Asked Questions

What led to Seelos Therapeutics being delisted from Nasdaq?

Seelos was unable to meet Nasdaq's minimum stockholder equity requirement, which resulted in the delisting decision.

What will happen to Seelos' stock after the delisting?

After delisting from Nasdaq, Seelos' stock will transition to trade on the OTCQB market, allowing for continued trading albeit with some uncertainties.

What research is Seelos currently conducting?

Seelos is conducting research on its compound SLS-002 for treating PTSD, particularly among military personnel and veterans.

How did the market respond to the news about Seelos?

Following the announcement, SEEL shares dropped significantly, approximately 45.32%, trading around $1.34 per share.

What is the focus of the clinical trial with the Department of Defense?

The clinical trial aims to assess the effectiveness, safety, and tolerability of Seelos' SLS-002 compound for PTSD treatment in military members and veterans.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lufax's Q3 Struggles: Rising Losses Amid Income Drop

Updated Category News Views 79

Noteworthy Changes in Lufax's Financial Landscape Diving into Lufax's third quarter of 2026, it's clear as day that the numbers are drawing a grim picture. Lufax, a heavyweight in financial services for small business owners in China, announced unflattering financial results. The headline here? A net loss of RMB1,494 million, far from the RMB380 million lost the previous...

Continue Reading
USDA Loans in Pampa: Clearing Up Misconceptions

Updated Category News Views 72

Understanding USDA Loans in Pampa When it comes to buying a home in Pampa, Texas, there's a lot of chatter about USDA loans, and a fair bit of confusion too. Now, real estate expert Patti Hudson is cutting through the noise and setting the record straight, making sure families know all the facts before diving into the housing market. Not Just for Rural Areas Let's squash...

Continue Reading
CapCut Leads 2026 AI Image Tools for Creatives

Updated Category News Views 29

CapCut Emerges as a Go-To in AI Imagery There's no better feeling than striking gold in a flooded market. CapCut's got folks buzzing in 2026 for its top-tier AI image creation tools, according to Expert Consumers' latest rankings. On the surface, it might just seem like another tech gimmick, but dig a bit deeper, and you'll see why it's a game changer. From adland to...

Continue Reading
New Ambulatory Surgery Center in Alabama Breaks Ground

Updated Category News Views 18

Breaking New Ground: USOP and SOS Lead the Charge You can almost hear the construction noise starting up in Montgomery, Alabama, where U.S. Orthopaedic Partners (USOP) and Southern Orthopaedic Surgeons (SOS) have just launched an ambitious new project. They're not just cutting ceremonial ribbons; they're slicing into the future of orthopedic care in Central Alabama. The...

Continue Reading
Liz Parrish's Bold Take on Gene Therapy and Aging

Updated Category News Views 27

A Mother's Quest: From Personal Struggles to Professional Breakthroughs Never underestimate a mother's determination. When Liz Parrish's son was diagnosed with Type 1 diabetes, it sparked a relentless drive in her to find answers beyond conventional medicine. This journey led Parrish, CEO of BioViva Sciences USA Inc., not just into the cutting-edge world of gene therapy,...

Continue Reading
oToBrite Unveils Avant-Garde Robotics Vision Tech at ROBOTWORLD

Updated Category News Views 74

An Eye on the Future: oToBrite's Bold Vision for Robotics Strolling down the aisles at ROBOTWORLD 2026, there's a palpable energy buzzing around oToBrite's booth. These folks are showcasing vision technology that's not just about snapping slick photos—it's about reshaping how machines see the world. And, let me tell you, if there’s one place to flaunt cutting-edge...

Continue Reading
Seasonal Hiring Booms as Firms Eye Long-Term Talent

Updated Category News Views 70

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

Continue Reading
Red Robin Faces Board Shakeup and Financial Strategy Shift

Updated Category News Views 49

Turbulence on the Board But Strategic Moves on Track Well, it's not every day you hear about a double departure from Red Robin's board, right on the heels of some big financial reshuffling. Two directors, James C. Pappas and Christopher Martin, decided to abandon ship effective October 23, 2026. Given their ties to JCP Investment and Jumana Capital, this isn't just a...

Continue Reading
Medical Device Manufacturing: $135B Market by 2031

Updated Category News Views 96

Skyrocketing Demand in Medical Device Manufacturing You're looking at a market that's gearing up to hit a whopping $135.47 billion by 2031. That's a big leap from its $85.59 billion stature in 2026, showing a strong 9.6% compound annual growth rate (CAGR). Now, if that doesn't get your investor rollercoaster senses tingling, I don't know what will. Key Growth Drivers The...

Continue Reading
UPM Defies Market Challenges: Strong Q3 Cash Flow

Updated Category News Views 30

UPM's Impressive Q3 Performance Amidst Challenges UPM-Kymmene Corporation just dropped their Q3 numbers, and let me tell ya, there's a lot to digest. In the face of some pretty gnarly market conditions—think destocking and those pesky cost inflations—they've managed to pull a rabbit out of the hat with strong cash flow. That's not a small feat, folks; it's a damn...

Continue Reading

Top 5 Most Recently Viewed Articles

TD Cowen Affirms Positive Outlook on Tradeweb Markets Growth

Updated Category News Views 39

TD Cowen Maintains Buy Rating for Tradeweb Markets TD Cowen recently expressed confidence in Tradeweb Markets (NASDAQ: TW), reinforcing its 'Buy' rating and setting a price target of $139.00. This endorsement comes on the heels of Tradeweb's recent release of trading metrics, which exceeded market expectations for September, showcasing robust performance across major...

Continue Reading
Rocket Alumni Solutions Transforms Donor Recognition Landscape

Updated Category News Views 21

Digital Recognition's New Era Donor recognition in educational institutions is getting a digital facelift, and Rocket Alumni Solutions is at the forefront of this transformation. In a world where tech means everything, schools are ditching static plaques for interactive digital displays. The Dynamic Power of Digital This ain't your granddad's donor wall. We're talking...

Continue Reading
EHang's Revolutionary Leap Toward Pilotless Aviation Dominance

Updated Category News Views 126

A New Era in Aviation: EHang's Vision In an industry where aeronautical innovations often hinge on pilot training and rigorous regulatory compliance, China's EHang Holdings Ltd (NASDAQ: EH) is in a league of its own. The Guangzhou-based eVTOL (electric Vertical Take-Off and Landing) manufacturer is paving the way for autonomous flying by operating commercial routes....

Continue Reading
BitMart's Innovative Strategies for Localizing Crypto Services

Updated Category News Views 156

Exploring BitMart's Strategic Localization Playbook In the world of cryptocurrency exchanges, the ability to adapt to cultural nuances and language preferences is paramount. BitMart, a prominent player in this arena, is making headlines with its recent localization initiatives, particularly through its rebranding to “??.” This substantial shift aims to bridge the gap...

Continue Reading